Cancer News
OncoLink Cancer News - HealthDay


Gut Microbiome Analysis Aids Colorectal Cancer Screening

Thursday, August 7, 2014 (Last Updated: 08/08/2014)

THURSDAY, Aug. 7, 2014 (HealthDay News) -- Analysis of the gut microbiome can better distinguish healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer, compared to use of traditional clinical risk factors and fecal occult blood testing, according to a study published online Aug. 7 in Cancer Prevention Research.

Joseph P. Zackular, Ph.D., from the University of Michigan in Ann Arbor, and colleagues characterized the gut microbiome from stool samples in patients from three clinical groups representing the stages of colorectal cancer development: healthy, adenoma, and carcinoma.

The researchers found that gut microbiome reveals both an enrichment and depletion of several bacterial populations associated with adenomas and carcinomas. Data from the gut microbiome combined with known clinical risk factors of colorectal cancer (i.e., body mass index, age, and race) significantly improved the ability to differentiate between healthy, adenoma, and carcinoma clinical groups beyond risk factors alone. Using gut microbiome data as a screening tool improved the pretest to posttest probability of adenoma more than 50-fold.

"The results of our study demonstrate the feasibility of using the composition of the gut microbiome to detect the presence of precancerous and cancerous lesions," the authors write.

Abstract
Full Text (subscription or payment may be required)

Specialties Hematology & Oncology
Gastroenterology
Surgery

Copyright © 2014 HealthDay. All rights reserved.


I Wish You Knew

Making treatment decisions is difficult and you can ask for help

View More







OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More